March 2013

J Psychiatry Neurosci 2013;38(2)

Editorial

A way forward for research on biomarkers for psychiatric disorders
P. Boksa

Commentary

Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin
S.N. Young

Review Paper

Overview of potential procedural and participant- related confounds for neuroimaging of the resting state
N.W. Duncan, G. Northoff

Research Papers

Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task
I. Suridjan, P. Rusjan, J. Addington, A.A. Wilson, S. Houle, R. Mizrahi

Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden
J. de Diego-Adeliño, M.J. Portella, B. Gómez-Ansón, O. López-Moruelo, M. Serra-Blasco, Y. Vives, D. Puigdemont, R. Pérez-Egea, E. Álvarez, V. Pérez

Recruitment of the left hemispheric emotional attention neural network in risk for and protection from depression
D.M. Lisiecka, A. Carballedo, A.J. Fagan, Y. Ferguson, J. Meaney, T. Frodl

Morphometric differences in central stress-regulating structures between women with and without borderline personality disorder
A. Kuhlmann, K. Bertsch, I. Schmidinger, P.A. Thomann, S.C. Herpertz

Psychopharmacology for the Clinician

Antidepressants and QTc prolongation
R.W. Lam